The study demonstrated that GBM patients had significantly higher expression of ADAM9 in comparison to LGG patients, while among LGG patients, aggressive astrocytic tumors displayed significantly higher ADAM9 expression than oligodendroglial tumors [58]. The gene discussed is ADAM9; the disease is oligodendroglial tumor.